Introduction 14
Delivery of biological molecules and fluorescent probes into living cells and tissues is of great 15 importance. [1, 2] A broad range of cationic polymers, lipids, transfection and complex-16 assembling reagents, as well as nanomaterials have been widely used in cytosolic delivery. [3] [4] [5] [6] [7] [8] [9] [10] [11] 17 However, many factors affect the efficiency of cargo molecules delivery, such as cell type, 18 cell number, media, carrier-relating cytotoxicity and low transfection efficacy for hard 19 transfecting cells. [12, 13] Recently, as a physical approach, vertical nanostructure arrays are 20 reported to conveniently facilitate intracellular delivery with high throughput.
[14] For example, 21 vertical silicon nanowires have been developed as a universal platform for transporting a 22 range of cargos into living cells, including DNAs, RNAs, peptides and proteins. [3, 15] In the 23 delivering process, cells are cultured on the vertical nanostructures for a period of time so that 24 the nanowires spontaneously penetrate cell's membranes and the pre-coated biomolecules on 25 the nanostructures can be slowly released into the cells. Similarly, aluminium oxide 26 nanostraws have also been applied to deliver cargos into cells but the difference is that the 1 nanostraws are hollow and integrated with a reservoir so materials can be directly injected to 2 cells once the nanostraws pierce into cells during the culturing. [16] The advantage of these 3 methods is that biomolecules can be transported into cells without the requirement of 4 chemical modification or viral packaging. However, some cell functions might be perturbed 5
by culturing on such nanostructures for extended period of time. For example, it has been 6 discovered that HeLa cells grow slowly [17] and temporarily develop irregular contours when 7 culturing on silicon nanowires and the penetration of nanowires into cells leads to lipid 8 scrambling although this can be reversed in healthy cells. [15] In addition, Persson et al. 9 explored that fibroblasts cultured on similar nanostructures display impaired cell division, 10 increased reactive oxygen species (ROS) content and ultimately DNA damage. [18] Liu et al. 11
found that mesenchymal stem cells exhibit significantly different adhesion, proliferation and 12 differentiation behavior when compared to those on flat substrates. [19] 13
To alleviate these problems, we developed diamond nanoneedle arrays for enhanced 14 intracellular delivery. [20] [21] [22] In our approach, instead of culturing cells on the vertical 15 nanostructures for spontaneous penetration over a period, we allow the nanoneedles to 16 actively disrupt the cell membranes within a very short duration (e.g., seconds to minutes) by 17 a precisely controlled centrifugation force or applying a cell suspension to the nanostructures 18 with a certain speed. [20] [21] [22] This platform has been demonstrated capable of effectively 19 delivering fluorescent cell probes (iridium(III) polypyridine complex, FITC-dextran, 20 propidium iodide (PI), and calcein AM, semiconductor quantum dots), drug molecules 21 (cisplatin), and genes (siRNA and DNA) to various cell lines. [20, 21, 23] Very recently, with a 22 similar manner, carbon nanosyringe arrays have also been employed to facilitate the delivery 23 of bioactive molecules to hard-to-transfect cells.
[24] Beyond these in vitro uses on cell lines, 24 biodegradable silicon nanoneedles with 50-nm-diameter tips are applied in vivo to transfect 25 VEGF-165 gene and induce sustained neovascularization.
[25] This work sets a new milestone 26 in the application of nanoneedle arrays for delivering biological functional molecules to the 1 cells in living tissues. 2
Despite the promising future of this new approach, the effect of the method on cell 3 physiology has not been investigated although it is of great importance to the design of the 4 nanostructures and operation parameters. In this study, we apply cells in a suspension to 5 diamond nanoneedle arrays with centrifugation force for efficient intracellular delivery and 6 then investigate the potential influence of the method on cell's DNA, ROS content, 7 mitochondrial membrane potential and glucose-6-phosphate dehydrogenase (G6PD) activity. 8
These findings will certainly improve our understanding of the technology of using this type 9 of vertical nanostructures for intracellular delivery and should provide guidance to better 10 design the platform for practical applications. 11 12 2. Results and discussion 13
Fabrication of diamond nanoneedle arrays 14
Diamond nanoneedle arrays were fabricated by forming a polycrystalline diamond thin film 15 first on silicon substrates followed by microwave plasma etching. We specifically chose 16 diamond to manufacture nanoneedle arrays because of its outstanding mechanical strength 17 and inertness. Two representative SEM images of diamond nanoneedle arrays are shown in 18 
Diamond nanoneedle arrays to facilitate intracellular delivery 21
In our previous reports [20, 22] , we used diamond nanoneedle arrays to improve intracellular 22 delivery by applying a cell suspension to the nanostructures with a certain speed. The method 23 is high-throughput and effective but lack of precise control. To further improve this approach, 24 herein, we apply a cell suspension on a diamond nanoneedle arrays and then apply 25 centrifugation force to carefully control the interaction between cells and nanostructures for 1 enhanced intracellular delivery (Figure 1b) . At the end of the process, the cell suspension is 2 collected. 3
Before measuring the potential influence of the technology on cell physiology, we firstly 4 proved that this system could be used to rapidly transport fluorescent molecules into cells. In 5 our experiment, we chose FITC labelled dextran with large molecular weight of 10,000 6
Daltons for this evaluation and the results are presented in Since the nanoneedle platform has been proved to be an efficient system in cytosolic 8 delivery, we also expect that diamond nanoneedle arrays can enhance the delivery of drugs 9 into drug resistant cells. We tested the potential efficiency of this system in doxorubicin 10 Following cytotoxicity measurement, to find out whether our approach induces DNA 13 damage, we investigated the integrity of genomic DNA in cells. One response to double 14 strand DNA break is the need of phosphorylated histone variant H2AX (pH2AX) in the 15 recruitment of proteins responsible for DNA repairing. [26, 27] In other words, the pH2AX 16
indicates DNA double-strand breaks. Therefore, we measured the level of DNA damage by 17 specific antibody-based detection of pH2AX in nucleus. In the test, cells were treated by 18 diamond nanoneedle arrays followed by culturing in a 96-well plate for 3, 6 and 24 hours. 19
Untreated cells were again used as a negative control group. Then all of the groups of cells 20 with different culturing times were labelled with pH2AX mouse monoclonal antibody. 21
Subsequently, a fluorescent secondary antibody was used to bind to the primary pH2AX 22 antibody and the fluorescence intensities were determined for quantity analysis of pH2AX. 23
As shown in Figure 3b , the amount of pH2AX does not have significant difference between 24 the control group and the group treated by nanoneedle arrays at all 3 different time points.This indicates that the diamond nanoneedle array treatment does not lead to DNA double-1 strand breaks. 2
Besides genotoxicity, we also measured the integrity of cytoplasm membrane at 3, 6, and 3 24 hours after diamond nanoneedle array treatment with the image-iT dead green viability 4 stain. We previously demonstrated that diamond nanoneedle disruption to cells can lead to the 5 permeation of ethidium homodimer-1 (EthD-1) through the cell membranes.
[21] EthD-1 is a 6 high-affinity nucleic acid stain that is weakly fluorescent until bound to DNA and emits red 7
fluorescence. In the test, EthD-1 was applied when cells were undergoing nanoneedle 8 treatment. However, here, we add Image-iT dead green at 3, 6, and 24 hours after nanoneedle 9 treatment. Image-iT dead green staining is a microscopy-based fluorescent assay for dead 10 cells. It is impermeable to health cells but become permeant when the cytoplasm membrane is 11 compromised. The result about image-iT dead green staining is presented in Figure 3c . It is 12 clear that there is negligible difference of fluorescence intensity between the untreated cells 13 and the group treated by nanoneedle arrays at different time points, suggesting that the cell 14 membranes recover their integrity soon after nanoneedle disruption (Figure 3c) . 15
We next monitored the release of glucose 6-phosphate dehydrogenase (G6PD) from 16 treated cells into the surrounding medium. G6PD is a cytosolic enzyme and can leak from 17 dead cells. The released amount of G6PD in cell medium correlates with the number of dead 18 cells in the sample. Since the level of G6PD activity in common cell culture sera is much 19 lower than many other enzymes, such as lactate dehydrogenase, this assay can be more 20 precise and effective. A549 cells were treated with a diamond nanoneedle arrays following by 21 24 hours culturing in a 96-well plate. The extracellular G6PD level was detected by following 22 the vibrant cytotoxicity assay kit. The mechanism is to oxidise glucose 6-phosphate by G6PD 23 and generate NADPH, which cause the reduction of resazurin (a blue dye) to yield fluorescent 24 resorufin for measurement. Cell culture medium and untreated cells were used as two control 25 groups. The result shows that there is no significant difference among these three groups inthe amount of extracellular G6PD (Figure 3d ). These findings suggest that diamond 1 nanoneedle treatment delivering system not affect the viability of the cells. This is in line with 2 the result shown in Figure 3a . 3
Nanoneedle treatment leads to apoptosis 4
After confirming that diamond nanoneedle treatment does not cause measurable necrosis and 5 DNA damage and the cell membrane integration at 3 hours after treatment is also not affected, 6 we then investigate whether the nanoneedle will lead to cell apoptosis and influence the 7 intracellular G6PD level. 8
For cell apoptosis measurement, A549 cells were treated with a diamond nanoneedle 9 array followed by culturing for 24 hours. Subsequently, the cells were tested by alexa fluor 10 488 annexin V/dead cell apoptosis kit. Annexin V was used as a probe to monitor apoptotic 11 signals. In apoptosis, phosphatidylserine is exposed to the external cellular environment 12 through lipid scrambling and annexin V can specifically bind to phosphatidylserine for 13 Comparing with the control group, the cytosolic delivery of calcein-AM is dramatically 20 enhanced when it was added immediately (0 min) after the cells being treated by nanoneedles 21 (Figure 5a ). This is within our expectation as the diamond nanoneedle treatment is supposed 22 to improve the permeability of the cell membrane. With the increase of the time, the cell 23 membrane should gradually recover and therefore the permeation of molecules into the cells 24 should slowly drop. After a certain period of time, the cell membrane is expected tomore. In line with this theory, we indeed find that the fluorescence intensity of the cells has 1 the highest value at 0 min. When calcein AM was added at 5, 10 and 20 mins after the cells 2 being treated by nanoneedles, the fluorescence intensities slightly drop because fewer 3 molecules are able to enter the cells. When calcein AM was added at 40 mins or later, the 4 fluorescence intensities fall to the level which is consistent with that of the control group 5 (Figure 5a, b) . This means that the cell membrane should have recovered its integrity. These 6 findings are in fact fully supported by the PI staining result. For example, when PI was added 7
to the medium at 40 mins or later, negligible PI molecules can enter the cells, so the 8 fluorescence can hardly be observed in the cells. We also calculate the percentages of PI From the fluorescence images shown in Figure 6b , we can see that, after 12 or 24 hours 1 incubation, nanoneedle array treatment could obviously elevate intracellular ROS production. 2
Nanoneedle treatment induces increased intracellular G6PD level 3
The results in Figures 4 and 6 show that nanoneedle treatment leads to slightly increased 4 apoptosis and higher ROS contents. When cells are jointly treated by nanoneedles and drug 5 molecules (e.g., cisplatin), these findings may partially explain the reason of the improved 6 drug efficacy when aided with nanoneedle treatment. However, according to our previous 7 cytotoxicity measurement, the nanoneedle treatment alone will not lead to measurable cell 8 death with MTT assay. We speculate that the elevated ROS level and apoptosis signal could 9
trigger the redox components to counteract the negative effect of nanoneedle treatment to the 10 physiology of the cells. The intracellular redox potential is determined by the ratio of oxidants 11 and reductants. Nicotinamide adenine dinucleotide phosphate (NADPH) is the principal 12 intracellular reductant that can be used by many enzymes for reducing power in cells such as 13 glutathione reductase and catalase.
[28] G6PD is the first and rate-limiting enzyme of pentose 14 phosphate (PP) signal pathway to determine the NADPH production by controlling the 15 metabolism of glucose via PP signal pathway.
[29] G6PD and NADPH have an essential role to 16 counterbalance the oxidative stress and protect cells from oxidative stress-induced 17 apoptosis. [30] [31] [32] To monitor the intracellular G6PD levels, A549 cells were treated with a 18 diamond nanoneedle array and the measurement was performed at 3, 6, 12 and 24 hours after 19 the treatment. For untreated cells, the test was also carried out at all different time points for 20 comparison. As shown in Figure 7 , compared with the control groups, the intracellular G6PD 21 level in A549 cells are dramatically increased with time increasing and reaches the highest 22 level at 12 hours and slowly drops to normal level after 48 hours culture. (Figure S5 , 23 Supporting Information). However, combining with the result shown in Figure 4 , we 24 speculate that the increased G6PD activity still could not completely balance the high ROS 25 content, and therefore the treatment still led to slight elevation of apoptosis signal pathway.
Depolarization of mitochondrial membrane potential 1
After knowing that the diamond nanoneedle array treatment can cause the production of ROS, 2 we next studied the possible reasons. Mitochondria is an important organelle that plays a 3 central role in cellular viability, such as heat generation, cell growth, cell death via apoptosis, 4 passive proton leak, formation and degradation of ROS.
[33-37] Via different experimental 5 models, it has been repeatedly demonstrated that a lower mitochondrial membrane potential is 6 observed with a simultaneously increase of ROS production. [38, 39] In this study, we used the 7
MitoProbe JC-1 assay kit to test mitochondrial membrane potential. JC-1 is a lipophilic dye 8 and can selectively enter into mitochondria with a reversible change of color from green (529 9 nm) to red (590 nm) as the membrane potential increases. The mitochondrial membrane 10 potential was detected at three different time points (0, 12 and 24 h). At first, the ratio of 11 red/green (R3/R2) decreases immediately after the nanoneedle arrays treatment. But after 12 12 hours, or longer (24 hours), the mitochondrial membrane potential recovers to normal ratio 13 when compared with control group (Figure 8) . This indicates that the depolarization of 14 mitochondrial membrane potential could be one of the reasons of the generation of ROS. 15
However, some production of non-mitochondrial ROS could not be completely excluded, 16 such as the membrane-bound NADPH oxidase [40] . Further experiments will be necessary to 17 understand the generation of ROS and its influence on the cell physiology. 18 19
Conclusion 20
In summary, our results show that centrifugation force regulated diamond nanoneedle 21 treatment of cell suspensions could deliver molecules into cells in an efficient way. 22
Attractively, the approach does not induce noticeable cytotoxicity indicated by the viability of 23 nanoneedle array treated cells and genotoxicity suggested by the lack of pH2AX expression. 24
However, the treatment leads to increased ROS content and cell apoptosis. The elevatedthat diamond nanoneedle array disruption can induce lipid scrambling and then affect the 1 intracellular metabolic signal pathways. For the cells only treated by our nanoneedle arrays, 2 these do not induce much cytotoxicity. The reason might be that their damaging to the cells is 3 partially counteracted by the elevation of G6PD. It is possible that the production of ROS 4 content during nanoneedle array treatment is partially caused by the decreased mitochondrial 5 membrane potential (Figure 9) . Importantly, by using calcein-AM and PI double staining, we 6 explored that the cell membranes should fully recover within 40 minutes after diamond 7 nanoneedle treatment. 8
In summary, this is the first report in which we systematically investigated the influence 9 of diamond nanoneedle array treatment on the metabolic signal pathways of cells. It could 10 provide a new arena for exploiting the nanoneedle application. 11 12
Experimental 13
Fabrication of diamond nanoneedle arrays: Diamond nanoneedle arrays were produced 14 by a top-down method. Firstly, polycrystalline diamond thin film was fabricated by 15
Microwave Plasma Chemical Vapor Deposition (MPCVD). N-type silicon wafer (100) -16 oriented, 1-10 Ω, was polished with diamond particle paste (0.25 μm) was used as a substrate. 17
Silicon substrate was then put into ultrasonic bath with alcohol and acetone for cleaning. 18
The ASTeX MWCVD reactor connected with a 1.5 kW microwave generator was 19 accounted for deposition of polycrystalline diamond film. Methane (CH4) and hydrogen (H2), 20 in the ratio 1% and 99% were being used as gas precursor, with the total flow rate of 300 21 SCCM. The temperature, pressure and microwave power were maintained at 800 Under this oxidant environment, the activity of intracellular redox enzymes G6PD is aroused 7 to counterbalance the high production of ROS. In the process, NADPH is synthesised and 8 utilized by the glutathione (GSH) mediated antioxidant defence. 9
